[1]
Powers WJ, Rabinstein AA, Ackerson T, et al. 2018 Guidelines for the early management of patients with acute ischemic stroke. Stroke 2018; 439(3): 509-10.
[2]
Brott TG, Hobson RW, Howard G, et al. Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med 2010; 363(1): 11-23.
[3]
Hoeffner EG, Case I, Jain R, et al. Cerebral perfusion CT: Technique and clinical applications. Radiology 2004; 231(3): 632-44.
[4]
Cianfoni A, Colosimo C, Basile M, et al. Brain perfusion CT: Principles, technique and clinical applications. Radiol Med 2007; 112(8): 1225-43.
[5]
Chin SC, Chang CH, Chang TY, et al. Brain computed tomography perfusion may help to detect hemodynamic reconstitution and predict intracerebral hemorrhage after carotid stenting. J Vasc Surg 2012; 56(5): 1281-90.
[6]
Hajduková L, Sobek O, Prchalová D, et al. Biomarkers of brain damage: S100B and NSE concentrations in cerebrospinal fluid-a normative study. BioMed Res Int 2015; 2015(4)379071
[7]
Turner RJ, Sharp FR. Implications of MMP9 for blood brain barrier disruption and hemorrhagic transformation following ischemic stroke. Front Cell Neurosci 2016; 10: 56.
[8]
Sandoval KE, Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 2008; 32(2): 200-19.
[9]
Kochanek PM, Berger RP, Bayr H, et al. Biomarkers of primary and evolving damage in traumatic and ischemic brain injury: Diagnosis, prognosis, probing mechanisms, and therapeutic decision making. Curr Opin Crit Care 2008; 14(2): 135-41.
[10]
Tejima E, Zhao BQ, Tsuji K, et al. Astrocytic induction of matrix metalloproteinase-9 and edema in brain hemorrhage. J Cereb Blood Flow Metab 2007; 27(3): 460-8.
[11]
Zetterberg H, Smith DH, Blennow K. Biomarkers of mild traumatic brain injury in cerebrospinal fluid and blood. Nat Rev Neurol 2013; 9(4): 201-10.
[12]
Hayakata T, Shiozaki T, Tasaki O, et al. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock 2004; 22(2): 102-7.
[13]
Waaijer A, Van der Schaaf IC, Velthuis BK, et al. Reproducibility of quantitative CT brain perfusion measurements in patients with symptomatic unilateral carotid artery stenosis. Am J Neuroradiol 2007; 28(5): 927-32.
[14]
Chin SC, Chang CH, Chang TY, et al. Brain computed tomography perfusion may help to detect hemodynamic reconstitution and predict intracerebral hemorrhage after carotid stenting. J Vasc Surg 2012; 56(5): 1281-90.
[15]
Li DD, Song JN, Huang H, et al. The roles of MMP-9/TIMP-1 in cerebral edema following experimental acute cerebral infarction in rat. Neurosci Lett 2013; 550: 168-72.
[16]
Asahi M, Wang X, Mori T, et al. Effects of matrix metalloproteinase-9 gene knock-out on the proteolysis of blood–brain barrier and white matter components after cerebral ischemia. J Neurosci 2001; 21(19): 7724-32.
[17]
Kapural M, Krizanac-Bengez LJ, Barnett G, et al. Serum S-100β as a possible marker of blood–brain barrier disruption. Brain Res 2002; 940(1-2): 102-4.
[18]
Tanaka Y, Marumo T, Omura T, et al. Early increases in serum S100B are associated with cerebral hemorrhage in a rat model of focal cerebral ischemia. Brain Res 2008; 1227: 248-54.
[19]
Sen J, Belli A. S100B in neuropathologic states: The CRP of the brain? J Neurosci Res 2007; 85(7): 1373-80.
[20]
Gautier S, Ouk T, Petrault O, et al. Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia. Br J Pharmacol 2009; 156(4): 673-9.
[21]
Zhang JH, Li JK, Ma LL, et al. RNA interference-mediated silencing of S100B improves nerve function recovery and inhibits hippocampal cell apoptosis in rat models of ischemic stroke. J Cell Biochem 2018; 119(10): 8095-111.
[22]
Dragas M, Koncar I, Opacic D, et al. Fluctuations of serum neuron specific enolase and protein S-100B concentrations in relation to the use of shunt during carotid endarterectomy. PLoS One 2015; 10(4)e0124067
[23]
Gonçalves CA, Leite MC, Nardin P. Biological and methodological features of the measurement of S100B, a putative marker of brain injury. Clin Biochem 2008; 41(10-11): 755-63.
[24]
Kimura F, Kadohama T, Kitahara H, et al. Serum neuron-specific enolase level as predictor of neurologic outcome after aortic surgery. Thorac Cardiovasc Surg 2019; 22. [Epub ahead of print].
[25]
Mattusch C, Diederich KW, Schmidt A, et al. Effect of carotid artery stenting on the release of S-100B and neurone-specific enolase. Angiology 2011; 62(5): 376-80.
[26]
Lin L, Wang X, Yu Z. Ischemia-reperfusion injury in the brain: Mechanisms and potential therapeutic strategies. Biochem Pharmacol 2016; 5(4): pii 213.
[27]
Waaijer A, Van der Schaaf IC, Velthuis BK, et al. Reproducibility of quantitative CT brain perfusion measurements in patients with symptomatic unilateral carotid artery stenosis. Am J Neuroradiol 2007; 28(5): 927-32.
[28]
Chin SC, Chang CH, Chang TY, et al. Brain computed tomography perfusion may help to detect hemodynamic reconstitution and predict intracerebral hemorrhage after carotid stenting. J Vasc Surg 2012; 56(5): 1281-90.
[29]
Wintermark M, Flanders AE, Velthuis B, et al. Perfusion-CT assessment of infarct core and penumbra: Receiver operating characteristic curve analysis in 130 patients suspected of acute hemispheric. Stroke 2006; 37: 979-85.
[30]
Yoshie T, Ueda T, Takada T, et al. Prediction of cerebral hyperperfusion syndrome after carotid artery stenting by CT perfusion imaging with acetazolamide challenge. Neuroradiology 2016; 58(3): 253-9.
[31]
Merckel LG, Van der Heijden J, Jongen LM, et al. Effect of stenting on cerebral CT perfusion in symptomatic and asymptomatic patients with carotid artery stenosis. Am J Neuroradiol 2012; 33(2): 280-5.
[32]
Yang B, Chen W, Yang Y, et al. Short-and long-term hemodynamic and clinical effects of carotid artery stenting. Am J Neuroradiol 2012; 33(6): 1170.
[33]
Scarcello E, Morrone F, Piro P, et al. Protein S-100B as biochemical marker of brain ischemic damage after treatment of carotid stenosis. Ann Vasc Surg 2011; 25(7): 975-8.